Cite
MLA Citation
Masanori Atsukawa et al.. “Efficacy and safety of ombitasvir/paritaprevir/ritonavir and ribavirin for chronic hepatitis patients infected with genotype 2a in Japan.” Hepatology research, vol. 49, no. 4, 2019, pp. 369–376. http://access.bl.uk/ark:/81055/vdc_100080206230.0x00001d